Orgenesis (ORGS) Confirms Agreement for Sale of Masthercell Global

Go back to Orgenesis (ORGS) Confirms Agreement for Sale of Masthercell Global

Catalent (CTLT) Prices Common Share Offering for Gross Proceeds of Approx. $500M

February 4, 2020 5:39 AM EST

Catalent, Inc. (Catalent) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced the pricing of an underwritten public offering (the Offering) of shares of its common stock, which is expected to result in gross proceeds of approximately $500 million, before deducting estimated offering expenses. The underwriters may offer the shares of... More